New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
January 18, 2019 - The FDA announced the discontinuation of Leadiant Biosciences’ Adagen (pegademase bovine) 375 units/1.5 mL injection.
Download PDF
Return to publications
